[Form 3] Ingevity Corp Initial Statement of Beneficial Ownership

Ingevity Corp senior vice president of operations Clarence Reid Clontz, Jr. reported his beneficial ownership in the company as of the stated event date.

Rhea-AI Filing Summary

Ingevity Corp senior vice president of operations Clarence Reid Clontz, Jr. reported his beneficial ownership in the company as of the stated event date. He directly holds 7,029 shares of common stock.

He also holds employee stock options granted under the Ingevity Corporation 2016 Omnibus Incentive Plan. These options cover 217 shares at $53.11 per share that vested in full on February 27, 2020, 496 shares at $74.91 per share that vested in full on February 28, 2021, and 351 shares at $115.22 per share that vested in three equal installments between February 28, 2020 and February 28, 2022.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Clontz Clarence Reid Jr.

Role SVP, Operations

Type	Security	Shares	Price	Value
holding	Employee Stock Option (right-to-buy)	--	--	--
holding	Employee Stock Option (right-to-buy)	--	--	--
holding	Employee Stock Option (right-to-buy)	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Option (right-to-buy) — 1,064 contracts (Direct); Common Stock — 7,029 shares (Direct)

Footnotes (3)

1. F1. These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested in full on February 27, 2020.
2. F2. These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested in full on February 28, 2021.
3. F3. These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested ratably in three equal installments. The first installment vested on February 28, 2020; the second installment vested on February 28, 2021; and the third installment vested on February 28, 2022.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/18/2025 - 06:13 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Clontz Clarence Reid Jr.

(Last) (First) (Middle)

C/O INGEVITY CORPORATION 4920 O'HEAR AVE

SUITE 400

(Street)

NORTH CHARLESTON SC 29405

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/08/2025

3. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Operations

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,029	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right-to-buy)	02/27/2020(1)	02/27/2027	Common Stock	217	$53.11	D
Employee Stock Option (right-to-buy)	02/28/2021(2)	02/28/2028	Common Stock	496	$74.91	D
Employee Stock Option (right-to-buy)	02/28/2022(3)	02/28/2029	Common Stock	351	$115.22	D

Explanation of Responses:

1. These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested in full on February 27, 2020.

2. These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested in full on February 28, 2021.

3. These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested ratably in three equal installments. The first installment vested on February 28, 2020; the second installment vested on February 28, 2021; and the third installment vested on February 28, 2022.

Remarks:

Exhibits: Exhibit 24 - Power of Attorney

	Clarence Reid Clontz, Jr. By: Mavis G. Huger as Attorney-in-Fact	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.